InvestorsHub Logo
Followers 472
Posts 29749
Boards Moderated 1
Alias Born 11/12/2016

Re: None

Sunday, 11/12/2017 12:57:00 AM

Sunday, November 12, 2017 12:57:00 AM

Post# of 821321
$GRCK .01 close (CBD Company (low floater)

Extremely low market cap of under
1.5 million.

Latest News
http://m.marketwired.com/press-release/grey-cloak-tech-inc-to-introduce-cannabio-salve-at-mjbizcon-in-las-vegas-otcqb-grck-2240010.htm

All PR’s
http://www.otcmarkets.com/stock/GRCK/news

Free L2 link as its an OTCQB ticker
http://www.otcmarkets.com/stock/GRCK/quote

Share Structure , very tiny market cap & float for a CDB company
http://www.otcmarkets.com/stock/GRCK/profile

GRCK Security Details
Share Structure
Market Value1 $1,318,280 a/o Nov 09, 2017

Authorized Shares 500,000,000 a/o Nov 07, 2017

Outstanding Shares 141,143,444 a/o Nov 07, 2017

Float 133,823,444 a/o Nov 07, 2017


CEO video



37% insider ownership !
https://www.otcmarkets.com/financialReportViewer?symbol=GRCK&id=181626

Large insider ownership usually means they will want a substantial increase in the pps.

Article on acquisition (Uncompensated)
http://psinvestor.com/grey-cloak-delivers-eqova-acquision-with-solid-structure-sets-stage-for-rebound/

Another article
https://www.networknewswire.com/strategic-acquisition-enables-grey-cloak-tech-inc-s-grck-development-two-industries/

Recently Uplisted to OTCQB, Audited

Cancelled RS replaced with increased AS

Form 14PRE: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12360234.

The highlights:

- They are planning to vote on Dec 29 to increase the AS to 1 billion shares

- Reason for AS increase - "As a general matter, the Board of Directors does not believe the currently available number of unissued shares of Common Stock is an adequate number of shares to assure that there will be sufficient shares available for issuance in connection with possible future acquisitions, equity and equity-based financings, possible future awards under employee benefit plans, stock dividends, stock splits, and other corporate purposes."
- Insiders and 5% stakeholders own around 168 million shares of common stock

Company is targeting a niche market with products ready to sell and an experienced management team who own 90 million shares (skin in the game). See form 4 & 3’s

Warrants at .25

Strong following on Twitter (74,000)


Eqova are Clinical-grade CBD products.

“Eqova's products are created using full spectrum hemp oil and other ingredients to achieve standardized dosing. These formulations combine the scientifically validated, powerful benefits of cannabinoids in standardized products, which are then distributed to patients under the care of licensed health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing clinical-grade products made in cGMP Compliant Labs located in the United States.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.